DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:AJ91 - DE000A1A6WE6 - Common Stock
12.9 EUR
+0.1 (+0.78%)
We assign a fundamental rating of 6 out of 10 to AJ91. AJ91 was compared to 10 industry peers in the Health Care Technology industry. AJ91 has an excellent financial health rating, but there are some minor concerns on its profitability. AJ91 has a decent growth rate and is not valued too expensively. Finally AJ91 also has an excellent dividend rating. These ratings could make AJ91 a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
AJ91 had positive earnings in the past year.
AJ91 had a positive operating cash flow in the past year.
Each year in the past 5 years AJ91 has been profitable.
Each year in the past 5 years AJ91 had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AJ91 (9.09%) is better than 80.00% of its industry peers.
AJ91 has a Return On Equity of 13.18%. This is in the better half of the industry: AJ91 outperforms 80.00% of its industry peers.
AJ91 has a Return On Invested Capital of 8.86%. This is in the better half of the industry: AJ91 outperforms 70.00% of its industry peers.
AJ91 had an Average Return On Invested Capital over the past 3 years of 9.31%. This is in line with the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROIC | 8.86% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
1.3 Margins
AJ91's Profit Margin of 9.82% is fine compared to the rest of the industry. AJ91 outperforms 70.00% of its industry peers.
In the last couple of years the Profit Margin of AJ91 has remained more or less at the same level.
The Operating Margin of AJ91 (12.33%) is better than 70.00% of its industry peers.
AJ91's Operating Margin has declined in the last couple of years.
AJ91 has a Gross Margin of 79.18%. This is in the better half of the industry: AJ91 outperforms 70.00% of its industry peers.
In the last couple of years the Gross Margin of AJ91 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% |
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
2. Health
2.1 Basic Checks
AJ91 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AJ91 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AJ91 has more shares outstanding
The debt/assets ratio for AJ91 has been reduced compared to a year ago.
2.2 Solvency
AJ91 has an Altman-Z score of 4.49. This indicates that AJ91 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.49, AJ91 is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
AJ91 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.49 |
ROIC/WACC1.27
WACC6.97%
2.3 Liquidity
A Current Ratio of 2.74 indicates that AJ91 has no problem at all paying its short term obligations.
AJ91 has a better Current ratio (2.74) than 80.00% of its industry peers.
AJ91 has a Quick Ratio of 2.50. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
AJ91 has a better Quick ratio (2.50) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 133.18% over the past year.
AJ91 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.57% yearly.
Looking at the last year, AJ91 shows a small growth in Revenue. The Revenue has grown by 0.69% in the last year.
AJ91 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.68% yearly.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.40, the valuation of AJ91 can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.25, AJ91 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.4 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AJ91 is valued cheaper than 90.00% of the companies in the same industry.
80.00% of the companies in the same industry are more expensive than AJ91, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.05 | ||
| EV/EBITDA | 4.22 |
4.3 Compensation for Growth
AJ91 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.17
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
AJ91 has a Yearly Dividend Yield of 5.86%, which is a nice return.
Compared to an average industry Dividend Yield of 1.99, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, AJ91 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
5.2 History
The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
The dividend of AJ91 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
FRA:AJ91 (1/12/2026, 7:00:00 PM)
12.9
+0.1 (+0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners7.92%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap65.40M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.86% |
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.4 | ||
| Fwd PE | N/A | ||
| P/S | 1.22 | ||
| P/FCF | 10.05 | ||
| P/OCF | 8.56 | ||
| P/B | 1.63 | ||
| P/tB | 1.64 | ||
| EV/EBITDA | 4.22 |
EPS(TTM)1.04
EY8.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY9.95%
OCF(TTM)1.51
OCFY11.68%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1.17
Graham Number13.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROCE | 14.96% | ||
| ROIC | 8.86% | ||
| ROICexc | 17.58% | ||
| ROICexgc | 17.72% | ||
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% | ||
| FCFM | 12.1% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.88% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.94% | ||
| Profit Quality | 123.15% | ||
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 4.49 |
F-Score6
WACC6.97%
ROIC/WACC1.27
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%
DOCCHECK AG / AJ91.DE FAQ
Can you provide the ChartMill fundamental rating for DOCCHECK AG?
ChartMill assigns a fundamental rating of 6 / 10 to AJ91.DE.
What is the valuation status of DOCCHECK AG (AJ91.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for DOCCHECK AG?
DOCCHECK AG (AJ91.DE) has a profitability rating of 6 / 10.
What is the financial health of DOCCHECK AG (AJ91.DE) stock?
The financial health rating of DOCCHECK AG (AJ91.DE) is 8 / 10.